Clinical Trial Update: A Clinical Study in Children and Adolescents With Mild to Moderate Atopic Dermatitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial in children and adolescents with mild to moderate atopic dermatitis conducted by Bayer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Snippet

Sponsor: Bayer | Conditions: Mild to Moderate Atopic Dermatitis | Phase 4 | Status: COMPLETED